There were no differences in circulating CCN4 levels between subjects with (88.9 ± 20.1 pg/mL; n = 15) and without (73.8 ± 19.1 pg/mL; n = 5) NASH and between subjects with different fibrosis scores and NAS scores assessed histologically (Supplementary Figure S4). The gene discussed is CCN4; the disease is metabolic dysfunction-associated steatohepatitis.